Navigation Links
Kendle to Present at Robert W. Baird & Co. 2010 Health Care Conference
Date:9/8/2010

CINCINNATI, Sept. 8 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the Company will participate in the upcoming Robert W. Baird & Co. 2010 Health Care Conference on Sept. 14, 2010 at the St. Regis New York in New York City.

Kendle's formal presentation will be given by Stephen Cutler, PhD, Senior Vice President and Chief Operating Officer and Keith Cheesman, Senior Vice President and Chief Financial Officer at 1:45 p.m. Eastern Time.

The presentation will be webcast and may be accessed at www.kendle.com in the "Investors Events & Presentations" section or at http://www.wsw.com/webcast/baird16/kndl.    

Slides will be available by 11 a.m. on the day of the presentation at www.kendle.com in the "Investors Events & Presentations" section. The webcast will be archived for 90 days following the live presentation.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the world's largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Additional information and investor ki
'/>"/>

SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Kendle Appoints Jeffrey M. Zucker to Lead Global Patient Recruitment Efforts
2. Kendle Rated a Top CRO to Work with for Fourth Consecutive Year
3. Kendle Announces New Revolving Credit Facility
4. Kendle Announces Details Regarding Fourth Quarter and Full-Year 2009 Earnings Conference Call and Webcast
5. Kendle to Present at UBS Global Life Sciences Conference
6. Kendle to Present at Robert Baird 2009 Health Care Conference
7. Kendle Realigns C-Suite Leadership to Drive Increased Innovation, Productivity and Organizational Efficiency
8. Kendle Appoints Stephen Cutler, PhD Senior Vice President and Chief Operating Officer
9. Kendle Names Jarrod Pontius Chief Legal Officer
10. Kendle Expands Asia/Pacific Operations with Opening of Offices in Kuala Lumpur, Bangkok and Manila
11. Kendle Announces First Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... (PRWEB) September 18, 2014 Leatherwood ... FM-4910 listed material, to stay competitive in the ... These high-performance materials ultimately impact product quality and ... and owner. , Established in 1980 in Lewisville, ... as many fabricators have left the business. Much ...
(Date:9/18/2014)... , Sept. 18, 2014 /PRNewswire/ - Oncothyreon Inc. ... of previously announced concurrent but separate underwritten offerings of ... to the public of $2.00 per share, for expected ... its Series A Convertible Preferred Stock at a price ... gross proceeds of $20 million. Each share of Series ...
(Date:9/18/2014)... September 18, 2014 SeqLL Inc., ... (tSMS™) technology, announced today the closing of a ... led by Genomic Diagnostic Technologies, will increase the ... applications. , Founded in March 2013 by Daniel ... Analyst at Helicos BioSciences, SeqLL has continued to ...
(Date:9/18/2014)... developed a new microscopy technology that allows them ... higher-than-ever resolution. , Dubbed "Complementation Activated Light Microscopy" ... are an order of magnitude finer than conventional ... of biomolecules at the nanometer scale. , In ... Nature Communications , the researchers behind CALM used ...
Breaking Biology Technology:Leatherwood Plastics Selects Vycom’s Flametec PVC-C Material to Stay Competitive in Semiconductor and Lab Equipment Industries 2Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 2Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 3SeqLL Closes Series-A Funding Round for Expansion of Single Molecule Sequencing 2Scientists pioneer microscopy technique that yields fresh data on muscular dystrophy 2
... decision to return capital to stockholders through liquidationA ... Biotechnology Value Fund, L.P. ("BVF"), today announced ... ) voted overwhelmingly to remove the existing Board ... BVF,s nominees. The vote took place earlier today ...
... Human Genome Sciences, Inc. (Nasdaq: ... 4th Annual Citi Biotech Day will be webcast and ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO )A ... present a corporate overview on Wednesday, April 1, 2009 ...
... BUDAPEST, Hungary, and PRINCETON, N.J., March 27 Zinsser ... collaboration agreement for product distribution in the territory of ... about partnering with Zinsser Analytic. Zinsser is a leader ... around the world," said Dr. Ferenc Darvas, president and ...
Cached Biology Technology:Biotechnology Value Fund, L.P. Announces Overwhelming Support to Remove the Board of Directors of Avigen, Inc. at Special Meeting of Stockholders 2Zinsser Analytic and ThalesNano Collaborate on Distributing Products 2
(Date:9/18/2014)... world, are the ideal animal in which to study ... the ocean into tens of thousands of freshwater streams ... skeleton to adapt to the new environment. , Breeding ... have turned up one of the genes that controls ... that gene,s regulation in a freshwater population is associated ...
(Date:9/17/2014)... to reproductive technologies, the justice and well-being of ... to identify key issues, articulate their values and ... most defensible ways forward. But what are the ... The Hastings Center and the Presidential Commission for ... to publish a series of essays to highlight ...
(Date:9/17/2014)... in 2000 as an EC-FP5 four-year project, delivering its ... progress and successful participations in several EC projects, as ... Network project (EU BON), to increase the general ... to extend the general dissemination of the Fauna Europaea ... has applied its novel e-Publishing tools to prepare data ...
Breaking Biology News(10 mins):Counting fish teeth reveals regulatory DNA changes behind rapid evolution, adaptation 2Counting fish teeth reveals regulatory DNA changes behind rapid evolution, adaptation 3Why bioethics literacy matters 2Why bioethics literacy matters 3Contributions on Fauna Europaea: Data papers as innovative model on expert involvement 2
... tungsten trioxide clusters line up molecule-by-molecule on the titanium ... raised slightly, holding forth the potential to execute catalytic ... system, a simplified version of a catalyst that would ... chemists the exact structure and reaction mechanisms of metal ...
... the leading cause of most common colds, struck two ... graft dysfunction and death. The two were part of ... significant respiratory infection from HRV in both the upper ... affects only upper airway tissue. , The research appears ...
... For years, the brain chemical dopamine has been thought of ... in a way that rewards a person or animal for ... certain drugs like cocaine and heroin amplify this effect ?an ... , Now, a new study from the University of ...
Cached Biology News:Uniform tungsten trimers stand and deliver 2Common cold virus leads to death in lung transplant patients 2Pleasure and pain: Study shows brain's 'pleasure chemical' is involved in response to pain too 2Pleasure and pain: Study shows brain's 'pleasure chemical' is involved in response to pain too 3Pleasure and pain: Study shows brain's 'pleasure chemical' is involved in response to pain too 4
Mouse monoclonal antibody raised against a partial recombinant PRKG1. NCBI Entrez Gene ID = PRKG1...
... polyclonal antibody raised against a ... Immunogen: PPP4C (NP_002711, ... partial recombinant protein with GST ... Number: NM_002720 ...
Mouse monoclonal antibody raised against a full length recombinant GPT. NCBI Entrez Gene ID = GPT...
Mouse monoclonal antibody raised against a partial recombinant CAPG. NCBI Entrez Gene ID = CAPG...
Biology Products: